Activase and Cipro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Activase (alteplase) and Cipro (ciprofloxacin hydrochloride). Common drug interactions include rash among females and haemoglobin decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Activase and Cipro. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Activase?

Activase has active ingredients of alteplase. eHealthMe is studying from 7,526 Activase users. Check the latest studies of Activase.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.



On Jul, 19, 2026

36 people who take Activase and Cipro together, and have interactions are studied.

Activase and Cipro drug interactions.

What are the common drug interactions of Activase and Cipro, by gender? *:

female:

  1. Rash
  2. Renal tubular necrosis (death of kidney tubules)
  3. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  4. Weight increased
  5. Asthenia (weakness)
  6. Bradycardia (abnormally slow heart action)
  7. Dizziness
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Hyperkeratosis (thickening of the outer layer of the skin)

male:

  1. Haemoglobin decreased
  2. Dyspnoea (difficult or laboured respiration)
  3. Productive cough
  4. Pulmonary congestion (congestion in the lungs)
  5. Rhinorrhoea (watery mucus discharge from the nose)
  6. Sputum increased
  7. Vitamin d deficiency
  8. White blood cell count increased
  9. Anaemia (lack of blood)
  10. Drug ineffective

What are the common drug interactions of Activase and Cipro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Vitamin d deficiency
  2. White blood cell count increased
  3. Blood alkaline phosphatase increased
  4. Chest discomfort
  5. Dyspnoea (difficult or laboured respiration)
  6. Forced expiratory volume decreased (decreased lung expired air volume)
  7. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  8. Haemoglobin decreased
  9. Heart rate increased
  10. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

30-39:

n/a

40-49:

  1. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  2. Chronic kidney disease
  3. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  4. Lacrimation increased
  5. Lymphoma (cancer that begins in immune system cells)
  6. Neoplasm progression (growth of tumour)
  7. Renal failure (kidney dysfunction)

50-59:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Asthenia (weakness)
  3. Anaemia (lack of blood)

60+:

  1. Hypotension (abnormally low blood pressure)
  2. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  3. Weight increased
  4. Bradycardia (abnormally slow heart action)
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  7. Pyrexia (fever)
  8. Rigors (an episode of shaking or exaggerated shivering)
  9. Dyspnoea (difficult or laboured respiration)
  10. Abdominal pain

What are the existing conditions these people have? *

  1. Pain: 11 people, 30.56%
  2. Multiple Myeloma (cancer of the plasma cells): 10 people, 27.78%
  3. Constipation: 8 people, 22.22%
  4. Nausea (feeling of having an urge to vomit): 8 people, 22.22%
  5. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 7 people, 19.44%
  6. Nausea And Vomiting: 5 people, 13.89%
  7. Headache (pain in head): 4 people, 11.11%
  8. Indigestion: 4 people, 11.11%
  9. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 11.11%
  10. Stress And Anxiety: 4 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Activase and Cipro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Activase and Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Activase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Activase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on alteplase and ciprofloxacin hydrochloride (the active ingredients of Activase and Cipro, respectively), and Activase and Cipro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: